MDRX - Allscripts Healthcare Solutions, Inc.
NASDAQ
->
Healthcare
->
Health Information Services
Chicago,
United States
Type: Equity
MDRX price evolution
MDRX
| (in millions $) | 30 Sep 2022 | 30 Jun 2022 | 31 Mar 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $493.9 | $501.47 | $84.09 | $190.52 |
| Short term investments | ||||
| Net receivables | $262.44 | $235.13 | $244.86 | $508.68 |
| Inventory | ||||
| Total current assets | $810.77 | $828.77 | $1540.68 | $761.34 |
| Long term investments | ||||
| Property, plant & equipment | $26.23 | $30.88 | $26.07 | $116.81 |
| Goodwill & intangible assets | $747.28 | $755.9 | $756.81 | $1382.51 |
| Total noncurrent assets | $879.89 | $885.45 | $889.57 | $1663.89 |
| Total investments | ||||
| Total assets | $1690.66 | $1714.22 | $2430.26 | $2425.23 |
| Current liabilities | ||||
| Accounts payable | $12.61 | $18.01 | $15.55 | $16.84 |
| Deferred revenue | $101.99 | $86.9 | $110.08 | $330.31 |
| Short long term debt | $6.17 | $6.09 | $5.97 | $19.6 |
| Total current liabilities | $253.09 | $256.33 | $646.86 | $547.08 |
| Long term debt | $212.64 | $213.77 | $392.3 | $414.88 |
| Total noncurrent liabilities | $260.55 | $261.54 | $430.29 | $470.01 |
| Total debt | $218.81 | $219.86 | $398.27 | $434.48 |
| Total liabilities | $513.64 | $517.87 | $1077.15 | $1017.09 |
| Shareholders' equity | ||||
| Retained earnings | $753.39 | $738.86 | $802.89 | $767.56 |
| Other shareholder equity | -$3.89 | -$3.93 | -$3.1 | -$2.77 |
| Total shareholder equity | $1177.02 | $1196.35 | $1353.11 | $1408.14 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $190.52 | $537.47 | $137.54 | $184.79 |
| Short term investments | ||||
| Net receivables | $508.68 | $497.75 | $459.75 | $465.26 |
| Inventory | ||||
| Total current assets | $761.34 | $1153.22 | $841.26 | $858.97 |
| Long term investments | $35.8 | $43.81 | $37.04 | |
| Property, plant & equipment | $116.81 | $168.76 | $186.36 | $121.91 |
| Goodwill & intangible assets | $1382.51 | $1454.53 | $1980.09 | $2014.48 |
| Total noncurrent assets | $1663.89 | $1764.4 | $2364.48 | $2322.52 |
| Total investments | ||||
| Total assets | $2425.23 | $2917.62 | $3205.74 | $3181.48 |
| Current liabilities | ||||
| Accounts payable | $16.84 | $35.91 | $104.01 | $73.17 |
| Deferred revenue | $330.31 | $338.24 | $392.18 | $482.78 |
| Short long term debt | $19.6 | $22.26 | $387.6 | $21.05 |
| Total current liabilities | $547.08 | $934.78 | $1210.69 | $797.73 |
| Long term debt | $414.88 | $261.05 | $646.17 | $648.31 |
| Total noncurrent liabilities | $470.01 | $316.6 | $709.86 | $803.33 |
| Total debt | $434.48 | $283.31 | $1033.77 | $669.36 |
| Total liabilities | $1017.09 | $1251.38 | $1920.55 | $1601.06 |
| Shareholders' equity | ||||
| Retained earnings | $767.56 | $633.12 | -$49.34 | $132.84 |
| Other shareholder equity | -$2.77 | -$1.84 | -$4.39 | -$5.39 |
| Total shareholder equity | $1408.14 | $1666.24 | $1285.19 | $1551.11 |
| (in millions $) | 30 Sep 2022 | 30 Jun 2022 | 31 Mar 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $151.92 | $150.9 | $142.67 | $391.7 |
| Cost of revenue | $68.49 | $71.42 | $69.19 | $222.71 |
| Gross Profit | $83.44 | $79.48 | $73.48 | $168.99 |
| Operating activities | ||||
| Research & development | $23.68 | $22.75 | $23.42 | $47.74 |
| Selling, general & administrative | $32.52 | $59.85 | $41.32 | $74.22 |
| Total operating expenses | $58.44 | $84.84 | $66.91 | $127.61 |
| Operating income | $25 | -$5.36 | $6.57 | $41.39 |
| Income from continuing operations | ||||
| EBIT | $29.64 | -$70.72 | $10.57 | $108.63 |
| Income tax expense | $13.87 | -$8.58 | -$14.42 | $17.9 |
| Interest expense | $1.25 | $1.89 | $2.14 | $3.46 |
| Net income | ||||
| Net income | $14.53 | -$64.03 | $22.86 | $87.28 |
| Income (for common shares) | $14.53 | -$64.03 | $22.86 | $87.28 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1503.04 | $1502.7 | $1771.68 | $1749.96 |
| Cost of revenue | $883.47 | $937 | $1058.1 | $1025.42 |
| Gross Profit | $619.57 | $565.7 | $713.58 | $724.54 |
| Operating activities | ||||
| Research & development | $193.67 | $206.06 | $254.51 | $268.41 |
| Selling, general & administrative | $313.81 | $389.94 | $419.77 | $450.97 |
| Total operating expenses | $534 | $696.58 | $738.04 | $645.34 |
| Operating income | $85.57 | -$130.88 | -$24.46 | $79.21 |
| Income from continuing operations | ||||
| EBIT | $175.46 | $717.82 | -$162.92 | $415.12 |
| Income tax expense | $27.85 | -$16.69 | -$23.91 | $0.47 |
| Interest expense | $13.17 | $34.1 | $43.17 | $50.91 |
| Net income | ||||
| Net income | $134.44 | $700.41 | -$182.18 | $363.74 |
| Income (for common shares) | $134.44 | $700.41 | -$182.18 | $315.15 |
| (in millions $) | 30 Sep 2022 | 30 Jun 2022 | 31 Mar 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Net income | $14.53 | -$64.03 | $22.86 | $87.28 |
| Operating activities | ||||
| Depreciation | $13.81 | $14.36 | $14.1 | $43.15 |
| Business acquisitions & disposals | $0.01 | $671.4 | -$23.02 | $61.23 |
| Stock-based compensation | $4.55 | $9.02 | $6.32 | $9.31 |
| Total cash flows from operations | $28.14 | -$1.64 | $69.26 | $65.04 |
| Investing activities | ||||
| Capital expenditures | -$8.17 | -$9.96 | -$9.95 | -$18.53 |
| Investments | -$1.09 | -$0.25 | ||
| Total cash flows from investing | -$9.25 | $657.17 | -$44.2 | $42.7 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$33.66 | -$93.69 | -$49.68 | -$108.49 |
| Net borrowings | -$177.66 | -$25 | ||
| Total cash flows from financing | -$38.45 | -$285.95 | -$62.97 | -$133.55 |
| Effect of exchange rate | -$0.72 | -$0.01 | $0 | |
| Change in cash and equivalents | -$19.57 | $368.87 | -$37.91 | -$25.8 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|
| Net income | $134.44 | $700.41 | -$182.18 | $363.74 |
| Operating activities | ||||
| Depreciation | $176.14 | $212.99 | $229.64 | $192.35 |
| Business acquisitions & disposals | $68.81 | $1710 | -$23.44 | $630.53 |
| Stock-based compensation | $35.17 | $34.04 | $38.98 | $34.64 |
| Total cash flows from operations | -$75.43 | -$106.72 | $46.25 | $67.89 |
| Investing activities | ||||
| Capital expenditures | -$78.56 | -$105.02 | -$130.44 | -$144.62 |
| Investments | -$2.42 | $17.87 | -$7.19 | -$16.93 |
| Total cash flows from investing | -$12.18 | $1615.19 | -$161.06 | $248.01 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$417.44 | -$334.86 | -$111.46 | -$137.65 |
| Net borrowings | $172.6 | -$768.86 | $239.89 | -$288.11 |
| Total cash flows from financing | -$258.87 | -$1109.76 | $67.34 | -$292.98 |
| Effect of exchange rate | -$0.48 | $1.21 | $0.2 | -$0.62 |
| Change in cash and equivalents | -$346.94 | $399.93 | -$47.26 | $22.3 |
News
Fundamentals
| Market cap | $524.45M |
|---|---|
| Enterprise value | $249.35M |
| Shares outstanding | 109.26M |
| Revenue | $837.19M |
|---|---|
| EBITDA | $163.55M |
| EBIT | $78.13M |
| Net Income | $60.63M |
| Revenue Q/Q | -58.86% |
| Revenue Y/Y | -39.73% |
| P/E ratio | 8.65 |
|---|---|
| EV/Sales | 0.30 |
| EV/EBITDA | 1.52 |
| EV/EBIT | 3.19 |
| P/S ratio | 0.63 |
| P/B ratio | 0.44 |
| Book/Share | 10.81 |
| Cash/Share | 4.52 |
| EPS | $0.55 |
|---|---|
| ROA | 2.94% |
| ROE | 4.72% |
| Debt/Equity | 0.72 |
|---|---|
| Net debt/EBITDA | 0.12 |
| Current ratio | 3.20 |
| Quick ratio | 3.20 |